Actuate Therapeutics ACTU
NASDAQ ACTU
$0.58 -0.04 (-6.31%)
As of: Oct 21, 2026 · 3:18 PM EDT

Actuate Therapeutics (ACTU) EBIT (2023 - 2026)

Updated

Actuate Therapeutics' EBIT came in at -$4.91 million for Q2 2026, compared with -$5.97 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) EBIT (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Actuate Therapeutics reported EBIT of -$21.04 million; for FY2025, it was -$22.5 million.

  • Going back by year, EBIT was -$25.16 million in FY2024 and -$24.97 million in FY2023.
  • The five-year range for quarterly EBIT is -$7.77 million (Q1 2024) to -$4.69 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,136.76 Bn 1,105.35 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 618.64 Bn 537.17 Bn 17.26 Bn 7.14 Bn
3 AbbVie 502.02 Bn 475.13 Bn 12.70 Bn 6.43 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.96 Bn 261.95 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.11 Bn 234.80 Bn 12.86 Bn 3.16 Bn
7 Amgen 236.64 Bn 192.04 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn -10.39 Bn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn 4.27 Bn
10 Actuate Therapeutics 13.79 Mn -27.22 Mn - -4.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.91 Mn
Dec 31, 2025 -4.69 Mn
Sep 30, 2025 -5.47 Mn
Jun 30, 2025 -5.97 Mn
Mar 31, 2025 -6.37 Mn
Dec 31, 2024 -6.56 Mn
Sep 30, 2024 -5.39 Mn
Jun 30, 2024 -5.44 Mn
Mar 31, 2024 -7.77 Mn
Dec 31, 2023 -7.62 Mn
Sep 30, 2023 -6.48 Mn
Jun 30, 2023 -5.58 Mn
API Access

Actuate Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ACTU&period=max&api_key=YOUR_API_KEY